TMEM106A antibody (N-Term)
Quick Overview for TMEM106A antibody (N-Term) (ABIN1450139)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 14 amino acid synthetic peptide near the amino terminus of human TMEM106A
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- TMEM106A (Transmembrane Protein 106A (TMEM106A))
-
Alternative Name
- TMEM106A
-
Background
- Transmembrane protein 106A (TMEM106A) is a single-pass transmembrane protein that is closely related to TMEM106B, a protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual roles of TMEM106A and TMEM106B are still undetermined, however, as TMEM106B is involved in FTLD, it is possible that TMEM106A may also be a risk factor for FTLD.Synonyms: Transmembrane protein 106A
-
Gene ID
- 113277
-
NCBI Accession
- NP_659478
Target
-